Fingerprint
Dive into the research topics of 'Nemolizumab in patients with moderate-to-severe atopic dermatitis: Randomized, phase II, long-term extension study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Nemolizumab in patients with moderate-to-severe atopic dermatitis: Randomized, phase II, long-term extension study
Kenji Kabashima, Masutaka Furue, Jon M. Hanifin, Grazyna Pulka, Andreas Wollenberg, Ryszard Galus, Takafumi Etoh, Ryosuke Mihara, Miwa Nakano, Thomas Ruzicka
Research output: Contribution to journal › Article › peer-review
194
Scopus
citations